Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Pharmadrug Inc C.PHRX

Alternate Symbol(s):  LMLLF

PharmaDrug Inc. is a Canada-based specialty pharmaceutical company. The Company is focused on the research, development and commercialization of controlled-substances and natural medicines, such as psychedelics and previously approved drugs. The Company’s subsidiary, Sairiyo Therapeutics (Sairiyo), is a biotech company that specializes in researching and reformulating established natural medicines. Sairiyo is engaged in the development of its patented reformulation of cepharanthine, a drug that has shown substantial third party validated potential for the treatment of infectious diseases and rare cancers. Sairiyo is also conducting research and development (R&D) in the psychedelics space for the treatment of non-neuropsychiatric conditions. The Company also operates through SecureDose Synthetics Inc., which is a pharmaceutical research and development company focused on the development of synthetic formulations of existing drugs for potential commercialization and distribution.


CSE:PHRX - Post by User

Comment by Guytoruleon Oct 31, 2024 10:43pm
60 Views
Post# 36291761

RE:RE:New debenture raise..to replace current debenture..!

RE:RE:New debenture raise..to replace current debenture..!Markets play to their own tune. Typical market trading moves bringing in substantial buying volume and later retraces back to its start. It brings in new investors and outs old stagnate investors (Old Money) slowly over time. Then you get another Speer of huge buying again, where you see higher highs. That's coming very soon in my opinion. As for money, I believe an issue is in the works at much higher price in my opinion, around .10 cents and shortly we may see PharmaTher, their 49% Owner of Sairiyo exercise their option to purchase up to 90% of Sairiyo and bring the cash needed in the short term, before they arrange their own financing deal. Things are looking good. Remember PharmaDrug has very low shares outstanding, 100mm, very low debt and much upside over the current share price having a measly market cap of $2 mm...should have a much higher valuation at this stage closer to $20 mm plus in my opinion, bring a potential share price to closer to .20 cents. A Multi-Bagger return....Risk/Reward is very lucrative here.
<< Previous
Bullboard Posts
Next >>